Article
EGFR mutations and abnormal trafficking in cancers.
Molecular biology reports - 21 Aug 2024
Kang Xiang, Li Rendong, Li Xiaolei, Xu Xinping
Abstract excerpt
Epidermal growth factor receptor (EGFR) is a transmembrane tyrosine kinase receptor and a member of the ErbB receptor family. As a significant cancer driver, EGFR undergoes mutations such as gene amplification or overexpression in a wide range of malignant tumors and is closely associated with tumorigenesis. This review examines the aberrant expression of EGFR in several common cancers and summarizes the current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
